Skip to content

ACN - 101321555 | ABN - 39101321555

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

AHRECS icon
  • Home
  • About Us
    • Consultants
    • Services
  • Previous Projects
  • Blog
  • Resources
  • Feeds
  • Contact Us
  • More
    • Request a Quote
    • Susbcribe to REM
    • Subscribe to VIP
Menu
  • Home
  • About Us
    • Consultants
    • Services
  • Previous Projects
  • Blog
  • Resources
  • Feeds
  • Contact Us
  • More
    • Request a Quote
    • Susbcribe to REM
    • Subscribe to VIP
Exclude terms...
Aboriginal and Torres Strait Islander
AHRECS
Analysis
Artificial Intelligence
Arts
Australia
Authorship
Belief
Beneficence
Big data
Biobank
Bioethics
Biomedical
Biospecimens
Breaches
Cartoon/Funny
Case studies
Clinical trial
Collaborative research
Conflicts of interest
Consent
Controversy/Scandal
Controversy/Scandal
Creative
Culture
Data management
Database
Dual-use
Essential Reading
Ethical review
Ethnography
Evaluative practice/quality assurance
First People
Fraud
Gender
Genetics
Good practice
Guidance
Honesty
HREC
Human research ethics
Humanities
Institutional responsibilities
International
Journal
Justice
Links
Media
Medical research
Merit and integrity
Methodology
Monitoring
New Zealand
News
Online research
Peer review
Performance
Primary materials
Principles
Privacy
Protection for participants
Psychology
Publication ethics
Questionable Publishers
Research ethics committees
Research integrity
Research Misconduct
Research results
Researcher responsibilities
Resources
Respect for persons
Sample paperwork
sd
Serious Adverse Event
Social Science
SoTL
Standards
Supervision
Training
Vulnerability
Young people
Exclude news

Sort by

Human Research Ethics Research Integrity

(France) French professor faces disciplinary case over hydroxychloroquine claims – The Guardian (November 2020)

Posted by Dr Gary Allen in Human Research Ethics, Research Integrity on November 20, 2020
Keywords: Breaches, Controversy/Scandal, Human research ethics, International, Medical research, News, Researcher responsibilities

The Linked Original Item was Posted On November 13, 2020

COVID-19 banner

Didier Raoult stands accused of touting drug as a coronavirus treatment without evidence

A French professor who touts the anti-malaria drug hydroxychloroquine as a coronavirus treatment – without evidence, scientists say – will appear before a disciplinary panel charged with ethics breaches, an order of doctors has said.

The stakes here cannot be overstated. This does serve as a ‘good’ example of the damage that can be done by cheats and those that look to cut corners.

Marseille-based Didier Raoult stands accused by his peers of spreading false information about the benefits of the drug. His promotion of hydroxychloroquine was taken up by the US and Brazilian presidents, Donald Trump and Jair Bolsonaro, who trumpeted its unproven benefits in a way critics say put people’s lives at risk.

No clinical trials have yet found in favour of using hydroxychloroquine against Covid-19, and critics say that due to potential serious side-effects, treating coronavirus patients with it is worse than no treatment at all.

Read the rest of this discussion piece

Related Reading

(UK) Study: Hydroxychloroquine had no benefit for hospitalized Covid-19 patients, possibly closing door to use of drug – STAT News (Matthew Herper | June 2020)

(EU) French hydroxychloroquine study has “major methodological shortcomings” and is “fully irresponsible,” says review, but is not being retracted – Retraction Watch (Ivan Oransky | July 2019)

Column: How a retracted research paper contaminated global coronavirus research – Los Angles Times (Michael Hiltzik | June 2020)

(US) FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy – STAT (Lev Facher | June 2020)

(France) French hydroxychloroquine-COVID-19 study withdrawn – Retraction Watch (Ivan Oransky | May 2020)

(France) He Was a Science Star. Then He Promoted a Questionable Cure for Covid-19 – New York Times Magazine (Scott Sayare | May 2020)

Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard” – Retraction Watch (Adam Marcus | April 2020)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Links

Complaints against Research Ethics Monthly

Request a Takedown

Submission Guidelines

About the Research Ethics Monthly

About subscribing to the Research Ethics Monthly

A diverse group discussing a topic

Random selected image from the AHRECS library. These were all purchased from iStockPhoto. These are images we use in our workshops and Dr Allen used in the GUREM.

Research Ethics Monthly Receive copies of the Research Ethics Monthly directly
by email. We will never spam you.

  • Home
  • Services
  • About Us
  • Contact Us
Menu
  • Home
  • Services
  • About Us
  • Contact Us
  • Company
  • Terms Of Use
  • Copyright
  • Privacy Policy
  • Disclaimer
Menu
  • Company
  • Terms Of Use
  • Copyright
  • Privacy Policy
  • Disclaimer
  • Support
  • Contact Us
  • Site Map
Menu
  • Support
  • Contact Us
  • Site Map

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Facebook-f
Twitter
Linkedin-in